UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000015910 |
|---|---|
| Receipt number | R000018518 |
| Scientific Title | Oocyte cryopreservation for fertility preservation of young woman in cancer, immune disease and the premature ovarian insufficiency |
| Date of disclosure of the study information | 2015/02/01 |
| Last modified on | 2018/02/20 07:18:19 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Oocyte cryopreservation for fertility preservation of young woman in cancer, immune disease and the premature ovarian insufficiency
Acronym
Oocyte cryopreservation for fertility preservation
Scientific Title
Oocyte cryopreservation for fertility preservation of young woman in cancer, immune disease and the premature ovarian insufficiency
Scientific Title:Acronym
Oocyte cryopreservation for fertility preservation
Region
| Japan |
Condition
Condition
Cancer patient including hematological malignancy, autoimmune disease such as SLE, premature ovarian insufficiency
Classification by specialty
| Medicine in general | Gastroenterology | Pneumology |
| Endocrinology and Metabolism | Hematology and clinical oncology | Nephrology |
| Clinical immunology | Surgery in general | Gastrointestinal surgery |
| Chest surgery | Endocrine surgery | Breast surgery |
| Obstetrics and Gynecology | Pediatrics | Dermatology |
| Oto-rhino-laryngology | Orthopedics | Urology |
| Radiology | Oral surgery | Neurosurgery |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
Verification of the effectiveness and safety in unfertilized oocyte cryopreservation as a clinical study for a fertility preservation
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Evaluation for a prospective advantage and disadvantage (including complication resulting from ovarian stimulation)
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Treatment
Type of intervention
| Medicine |
Interventions/Control_1
All the patients receive the same medical intervention
Period (routine ovarian stimulation)
Dosage of medicine (different among individuals)
Number of times (1-2 times of oocyte pick up)
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 15 | years-old | <= |
Age-upper limit
| 39 | years-old | >= |
Gender
Female
Key inclusion criteria
Long-term survival is anticipated.
15 years or older
39 years or younger
Key exclusion criteria
An agreement is not obtained
Patient who is judged to be inappropriate for this study
Patient for whom the start of therapy may be significantly delayed for this study
Target sample size
30
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Yasushi Takai |
Organization
Saitama Medical Center, Saitama Medical University
Division name
Department of Obstetrics and Gynecology
Zip code
Address
1981 Kamoda, Kawagoe, Saitama
TEL
049-228-3681
yastakai@saitama-med.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Yasushi Takai |
Organization
Saitama Medical Center, Saitama Medical University
Division name
Department of Obstetrics and Gynecology
Zip code
Address
1981 Kamoda, Kawagoe, Saitama
TEL
049-228-3681
Homepage URL
yastakai@saitama-med.ac.jp
Sponsor or person
Institute
Saitama Medical Center, Saitama Medical University
Institute
Department
Personal name
Funding Source
Organization
Saitama Medical Center, Saitama Medical University
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2015 | Year | 02 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Open public recruiting
Date of protocol fixation
| 2014 | Year | 12 | Month | 10 | Day |
Date of IRB
Anticipated trial start date
| 2015 | Year | 02 | Month | 01 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2014 | Year | 12 | Month | 10 | Day |
Last modified on
| 2018 | Year | 02 | Month | 20 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018518
